{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T02:10:51Z","timestamp":1780107051997,"version":"3.54.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,14]],"date-time":"2020-11-14T00:00:00Z","timestamp":1605312000000},"content-version":"am","delay-in-days":379,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lung-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lung Cancer"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.cllc.2019.06.003","type":"journal-article","created":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T12:49:57Z","timestamp":1560430197000},"page":"405-411","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Clinical Characteristics, Molecular Phenotyping, and Management of Isolated Adrenal Metastases From Lung Cancer"],"prefix":"10.1016","volume":"20","author":[{"given":"Antonio","family":"Mazzella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Loi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Mansuet-Lupo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Bobbio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene","family":"Blons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Damotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Alifano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cllc.2019.06.003_bib1","first-page":"69","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.cllc.2019.06.003_bib2","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1136\/thoraxjnl-2012-202297","article-title":"Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a population-based study, 2004\u20132007","volume":"68","author":"Walters","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.cllc.2019.06.003_bib3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","article-title":"Oligometastases","volume":"13","author":"Hellman","year":"1995","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2019.06.003_bib4","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/jjco\/hyp167","article-title":"Oligometastases and oligo-recurrence: the new era of cancer therapy","volume":"40","author":"Niibe","year":"2010","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.cllc.2019.06.003_bib5","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1200\/JCO.1991.9.9.1618","article-title":"Survival determinants in extensive-stage non-small cell lung cancer: the Southwest Oncology Group experience","volume":"9","author":"Albain","year":"1991","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2019.06.003_bib6","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1097\/JTO.0000000000000673","article-title":"The IASLC Lung Cancer Staging Project: proposals for the revision of the M descriptors in the forthcoming eight edition of the TNM classification of lung cancer","volume":"10","author":"Eberhardt","year":"2015","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2019.06.003_bib7","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.ijrobp.2014.04.007","article-title":"Definitive primary therapy in patients presenting with oligometastatic non-small cell lung cancer","volume":"89","author":"Parikh","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2019.06.003_bib8","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1200\/JCO.2007.14.2091","article-title":"Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non-small-cell lung cancer: a systematic review and pooled analysis","volume":"26","author":"Tanvetyanon","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2019.06.003_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/icvts\/ivw321","article-title":"Pooled analysis for surgical treatment for isolated adrenal metastasis and non-small cell lung cancer","volume":"24","author":"Gao","year":"2017","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.cllc.2019.06.003_bib11","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.jtho.2017.08.008","article-title":"The role of thoracic surgery in the therapeutic management of metastatic non-small cell lung cancer","volume":"12","author":"David","year":"2017","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2019.06.003_bib12","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/ejcts\/ezr042","article-title":"Which metastasis management allows long-term survival of synchronous solitary M1b non-small cell lung cancer?","volume":"41","author":"Mordant","year":"2012","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.cllc.2019.06.003_bib13","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.athoracsur.2018.10.029","article-title":"Synchronous oligometastatic lung cancer deserves a dedicated management","volume":"107","author":"Loi","year":"2019","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cllc.2019.06.003_bib14","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jmoldx.2018.04.002","article-title":"Validity of targeted next-generation sequencing in routine care for identifying clinically relevant molecular profiles in non-small-cell lung cancer: results of a 2-year experience on 1343 samples","volume":"20","author":"Legras","year":"2018","journal-title":"J\u00a0Mol Diagn"},{"key":"10.1016\/j.cllc.2019.06.003_bib15","first-page":"124","article-title":"Surgical treatment of adrenal metastasis following pulmonary resection for lung cancer: comparison of adrenalectomy with palliative therapy","volume":"79","author":"Higashiyama","year":"1994","journal-title":"Int Surg"},{"key":"10.1016\/j.cllc.2019.06.003_bib16","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0003-4975(97)01284-8","article-title":"Adrenalectomy for a solitary adrenal metastasis from lung cancer","volume":"65","author":"Porte","year":"1998","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cllc.2019.06.003_bib17","doi-asserted-by":"crossref","first-page":"6","DOI":"10.21037\/shc.2017.12.06","article-title":"Multimodality treatment of oligometastatic non-small cell lung cancer: review of literature","volume":"1","author":"Mazzella","year":"2017","journal-title":"Shanghai Chest"},{"key":"10.1016\/j.cllc.2019.06.003_bib18","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1245\/s10434-013-3050-2","article-title":"Outcome and prognostic factors after adrenalectomy for patients with distant adrenal metastasis","volume":"20","author":"Howell","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.cllc.2019.06.003_bib19","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/j.athoracsur.2011.05.116","article-title":"Outcomes of patients with isolated adrenal metastasis from non-small cell lung carcinoma","volume":"92","author":"Raz","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cllc.2019.06.003_bib20","doi-asserted-by":"crossref","DOI":"10.1177\/1176935117691267","article-title":"Significant prognostic features and patterns of somatic TP53 mutations in human cancers","volume":"16","author":"Zhang","year":"2017","journal-title":"Cancer Inform"},{"key":"10.1016\/j.cllc.2019.06.003_bib21","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1007\/s00280-016-3155-y","article-title":"EGFR mutation status of paired cerebrospinal fluid and plasma samples in EGFR mutant non-small cell lung cancer with leptomeningeal metastases","volume":"78","author":"Zhao","year":"2016","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.cllc.2019.06.003_bib22","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1515\/cclm-2017-0527","article-title":"Detection of EGFR, KRAS and BRAF mutations in metastatic cells from cerebrospinal fluid","volume":"56","author":"Frankel","year":"2018","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.cllc.2019.06.003_bib23","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11060-016-2081-5","article-title":"Tumor DNA in cerebral spinal fluid reflects clinical course in a patient with melanoma leptomeningeal brain metastases","volume":"128","author":"Li","year":"2016","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.cllc.2019.06.003_bib24","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.1158\/1078-0432.CCR-09-0089","article-title":"EGFR\/KRAS\/BRAF mutations in primary lung adenocarcinomas and corresponding locoregional lymphnode metastases","volume":"15","author":"Schmid","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cllc.2019.06.003_bib25","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/PPO.0000000000000202","article-title":"Stereotactic body radiotherapy for oligometastasis: opportunities for biology to guide clinical management","volume":"22","author":"Correa","year":"2016","journal-title":"Cancer J"},{"key":"10.1016\/j.cllc.2019.06.003_bib26","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1126\/science.aaf2784","article-title":"Metastasis as an evolutionary process","volume":"352","author":"Turajlic","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.cllc.2019.06.003_bib27","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.lungcan.2012.09.011","article-title":"Survival of patients treated surgically for synchronous single-organ metastatic NSCLC and advanced pathologic TN stage","volume":"78","author":"Collaud","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2019.06.003_bib28","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/jso.2930430306","article-title":"Do adrenal metastases from lung cancer develop by lymphogenous or hematogenous route?","volume":"43","author":"Karolyi","year":"1990","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.cllc.2019.06.003_bib29","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1245\/s10434-012-2464-6","article-title":"Renal origin and size are independent predictors of survival after surgery for adrenal metastasis","volume":"19","author":"Zerrweck","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.cllc.2019.06.003_bib30","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S1470-2045(09)70082-8","article-title":"Systemic effects of local radiotherapy","volume":"10","author":"Formenti","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cllc.2019.06.003_bib31","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.phrs.2015.06.011","article-title":"Immune therapy of non-small cell lung cancer. The future","volume":"99","author":"Bobbio","year":"2015","journal-title":"Pharmacol Res"}],"container-title":["Clinical Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730419301457?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730419301457?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:09:45Z","timestamp":1761505785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525730419301457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S1525730419301457"],"URL":"https:\/\/doi.org\/10.1016\/j.cllc.2019.06.003","relation":{},"ISSN":["1525-7304"],"issn-type":[{"value":"1525-7304","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Characteristics, Molecular Phenotyping, and Management of Isolated Adrenal Metastases From Lung Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cllc.2019.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}